Fayerweather Charles’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,050
Closed -$225K 72
2016
Q2
$225K Buy
+3,050
New +$216K 0.31% 67
2016
Q1
Sell
-3,050
Closed -$210K 70
2015
Q4
$210K Sell
3,050
-3,000
-50% -$198K 0.35% 64
2015
Q3
$358K Buy
6,050
+850
+16% +$53.9K 0.97% 36
2015
Q2
$346K Hold
5,200
0.88% 40
2015
Q1
$335K Hold
5,200
0.84% 44
2014
Q4
$307K Hold
5,200
1.04% 37
2014
Q3
$266K Hold
5,200
0.92% 39
2014
Q2
$252K Hold
5,200
0.86% 41
2014
Q1
$270K Hold
5,200
0.94% 38
2013
Q4
$277K Hold
5,200
0.97% 37
2013
Q3
$241K Hold
5,200
0.97% 35
2013
Q2
$232K Buy
+5,200
New +$226K 1.04% 36

Other funds holding BMY

Fayerweather Charles's BMY Position: Q3 2016 in Review

Fayerweather Charles sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 3,050 shares — an estimated $225K sold.

Fayerweather Charles first reported a position in BMY in Q2 2013 and held it in 12 quarters. The position peaked at $358K in Q3 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Fayerweather Charles reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Fayerweather Charles sold 3,050 Bristol-Myers Squibb shares in Q3 2016, an estimated $225K.
  • Fayerweather Charles first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 12 quarters.
  • Fayerweather Charles's Bristol-Myers Squibb position peaked at $358K in Q3 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Fayerweather Charles's 13F filing for Q3 2016, filed 16 Nov 2016.